CUSIP 03969K108COMARQTQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
278 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Suvretta Capital Management, LLC | 11.96M | $347.43M | +1.49M | Added |
| 2 | Frazier Life Sciences Management, L.P. | 9.87M | $286.76M | 0 | Held |
| 3 | Blackrock, Inc. | 9.10M | $264.25M | +525.6K | Added |
| 4 | Rubric Capital Management LP | 8.27M | $240.21M |
| −2.48M |
| Reduced |
| 5 | Vanguard Group Inc | 7.25M | $210.65M | +107.8K | Added |
| 6 | Jennison Associates LLC | 6.76M | $196.25M | −5.50M | Reduced |
| 7 | Polar Capital Holdings PLC | 5.56M | $161.35M | +257.4K | Added |
| 8 | State Street Corp | 5.49M | $159.38M | +847.0K | Added |
| 9 | Gilder Gagnon Howe & Co LLC | 4.45M | $129.34M | +24.7K | Added |
| 10 | Morgan Stanley | 4.34M | $126.04M | +63.8K | Added |
See every fund holding Arcutis Biotherapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders